Amneal to Report First Quarter 2022 Results on May 4, 2022
April 07 2022 - 08:00AM
Business Wire
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that
the Company will release its first quarter 2022 financial results
on Wednesday, May 4, 2022, prior to market open. The Company will
host a conference call and live webcast with the investment
community at 8:30 a.m. Eastern Time on May 4, 2022.
The financial results and live webcast will be accessible
through the Investor Relations section of the Company's website at
https://investors.amneal.com.
To access the call through a conference line, dial (844)
200-6205 (in the U.S.) or (929) 526-1599 (international callers).
The access code for the call is 874223.
A replay of the conference call will be posted shortly after the
call and will be available for seven days. To access the replay,
dial (866) 813-9403 (in the U.S.) or +44 (204) 525-0658
(international callers). The access code for the replay is
097886.
About Amneal
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in
Bridgewater, NJ, is a fully-integrated essential medicines company.
We make healthy possible through the development, manufacturing,
and distribution of generic and specialty pharmaceuticals,
primarily within the United States. The Company has a diverse
portfolio of approximately 250 products in its Generics segment and
is expanding across a broad range of complex products and
therapeutic areas, including injectables and biosimilars. In its
Specialty segment, Amneal has a growing portfolio of branded
pharmaceutical products focused primarily on central nervous system
and endocrine disorders, with a pipeline focused on unmet needs.
Through its AvKARE segment, the Company is a distributor of
pharmaceuticals and other products for the U.S. federal government,
retail, and institutional markets. For more, please visit
www.amneal.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220407005096/en/
Anthony DiMeo Head of Investor Relations
Anthony.DiMeo@amneal.com
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
From Mar 2023 to Mar 2024